...
首页> 外文期刊>BMC Medical Ethics >Ethics parallel research: an approach for (early) ethical guidance of biomedical innovation
【24h】

Ethics parallel research: an approach for (early) ethical guidance of biomedical innovation

机译:道德平行研究:(早期)生物医学创新的道德指导

获取原文
           

摘要

Our human societies and certainly also (bio) medicine are more and more permeated with technology. There seems to be an increasing awareness among bioethicists that an effective and comprehensive approach to ethically guide these emerging biomedical innovations into society is needed. Such an approach has not been spelled out yet for bioethics, while there are frequent calls for ethical guidance of biomedical innovation, also by biomedical researchers themselves. New and emerging biotechnologies require anticipation of possible effects and implications, meaning the scope is not evaluative after a technology has been fully developed or about hypothetical technologies, but real-time for a real biotechnology. In this paper we aim to substantiate and discuss six ingredients that we increasingly see adopted by ethicists and that together constitute “ethics parallel research”. This approach allows to fulfil two aims: guiding the development process of technologies in biomedicine and providing input for the normative evaluation of such technologies. The six ingredients of ethics parallel research are: (1) disentangling wicked problems, (2) upstream or midstream ethical analysis, (3) ethics from within, (4) inclusion of empirical research, (5) public participation and (6) mapping societal impacts, including hard and soft impacts. We will draw on gene editing, organoid technology and artificial intelligence as examples to illustrate these six ingredients. Ethics parallel research brings together these ingredients to ethically analyse and proactively or parallel guide technological development. It widens the roles and judgements from the ethicist to a more anticipatory and constructively guiding role. Ethics parallel research is characterised by a constructive, rather than a purely critical perspective, it focusses on developing best-practices rather than outlining worst practice, and draws on insights from social sciences and philosophy of technology.
机译:我们的人类社会和当然也(BIO)药物越来越渗透。生物学家似乎越来越令人越来越意识到,需要一种有效和综合的道德方式,导致这些新兴生物医学创新进入社会。这种方法尚未阐明生物伦理,而经常呼吁生物医学创新的道德指导,也由生物医学研究人员本身。新的和新兴的生物技术需要预期可能的影响和影响,这意味着在技术完全开发或关于假设技术的技术后,范围不是评估,而是真正的生物技术实时。在本文中,我们的目标是证实和讨论了六种成分,我们越来越多地看到伦理学家和共同构成“道德平行研究”。这种方法允许满足两个目的:指导生物医生技术的发展过程,并为这些技术的规范评估提供输入。道德并行研究的六种成分是:(1)解开邪恶问题,(2)上游或中游伦理分析,(3)内部的伦理,(4)纳入经验研究,(5)公共参与和(6)绘图社会影响,包括艰难和柔软的影响。我们将利用基因编辑,有机体技术和人工智能作为示例,以说明这六种成分。道德平行研究将这些成分融入了道德分析和主动或平行的指导技术发展。它从伦理主义者扩大了伦理主义的角色和判断,以更预期和建设性地指导的作用。道德并行研究的特点是建设性,而不是纯粹的批判性观点,它侧重于开发最佳实践而不是概述最糟糕的实践,并借鉴社会科学和技术哲学的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号